What is peptide cycling and why is it recommended?

Peptide cycling involves taking peptides for defined periods followed by breaks rather than continuous use. This approach is recommended for several reasons: preventing receptor desensitization (peptide receptors may downregulate with constant stimulation), allowing the body to maintain natural production of endogenous peptides, reducing the risk of long-term unknown side effects, minimizing costs, and preventing antibody formation that could reduce efficacy. Typical cycles vary by peptide: growth hormone secretagogues like CJC-1295/Ipamorelin often use 8-12 week cycles with 4-week breaks; healing peptides like BPC-157 might be used for 4-6 weeks during recovery periods; metabolic peptides may follow similar patterns. However, scientific evidence for optimal cycling protocols is limited, and recommendations are often based on anecdotal experience rather than clinical trials. Some peptides, like GLP-1 agonists for chronic conditions, are designed for long-term continuous use rather than cycling. Any cycling protocol should be developed with a knowledgeable healthcare provider based on specific goals and peptide mechanisms.